Fidelity Digital Assets (FDA) says diversifying an investment portfolio with bitcoin is especially essential now when benchmark interest rates globally are near or below zero. The opportunity cost of not allocating to bitcoin is simply higher explains FDA in its latest bitcoin investment thesis. FDA’s assertions come as one survey found that as many as 60% of investors surveyed believe that digital assets have a place in a portfolio.
As a consequence, Fidelity Digital Assets says that in these uncertain times, a diversified portfolio must consist of assets that lack a correlation with traditional assets over longer periods. Only a few assets possess such an attribute and bitcoin is one of them, according to FDA’s investment thesis titled, ‘Bitcoin’s Role as an Alternative Investment.’
In the thesis, FDA urges “investors looking to recalibrate their portfolios to evaluate the validity and